Healthcare Services Group, Inc. HCSG R2KR3KPHARMA
Company Overview
Healthcare Services Group, Inc. provides management, administrative, and operating services to the housekeeping, laundry, linen, facility maintenance, and dietary service departments of nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States. The company operates in two segments, Environmental Services and Dietary. Its Environmental Services segment engages in cleaning, disinfecting, and sanitizing of resident rooms and common areas of the customers' facilities, as well as the laundering and processing of the bed linens, uniforms, resident personal clothing, and other assorted linen items utilized at the customers' facilities. The Dietary segment is involved in the management of the customers' dietary departments, which focus on food purchasing, meal preparation, and professional dietitian services, such as the development of menus that meet the dietary needs of residents; and the provision of on-site management and clinical consulting services. It serves long-term and post-acute care facilities, hospitals, and the healthcare industry through referrals and solicitation of target facilities. The company was incorporated in 1976 and is headquartered in Bensalem, Pennsylvania.
Why Investors Should Care
Generates a return on equity of 24.7%, reflecting efficient use of shareholder capital.
Trades at a P/E of 12.8, below the sector median of 25.2.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $1.84B (+7.1% YoY); net profit $59.06M.
- Trailing 12 Months Year-on-year growth — revenue +2.7%, earnings +49.6%.
- 5-Year Trend Long-term compounding — revenue CAGR 2.0%, profit CAGR 5.1%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 2.04% |
| 1 Year: | 2.70% |
Compounded Profit Growth
| 5 Years: | 5.11% |
| 1 Year: | 49.63% |
Stock Price Performance
| 1 Year: | +42.89% |
| 6 Months: | +5.67% |
| 3 Months: | +7.12% |
| 1 Month: | -1.04% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMAAbove
- RSI (14)41.67 · Neutral
P/E of 12.76 is below the sector median of 25.17 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 24.7%.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Healthcare).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | HCSG Healthcare Services Group, Inc. R2KR3KPHARMA | 21.82 | 12.76 | $1.50B | 0.00% | 8.94% | 24.69% | 2.04% | 5.11% |
| 2 | LLY Eli Lilly and Company SPXR3KPHARMA | 1,149.36 | 38.57 | $1.02T | 0.58% | - | 102.29% | 7.20% | 11.41% |
| 3 | JNJ Johnson & Johnson SPXR3KPHARMA | 275.23 | 31.97 | $663.28B | 2.09% | 14.88% | 25.74% | 2.43% | 4.76% |
| 4 | ABBV AbbVie Inc. SPXR3KPHARMA | 256.46 | 72.45 | $453.19B | 2.84% | 10.47% | -129.24% | 1.75% | -29.06% |
| 5 | MRK Merck & Co., Inc. SPXR3KPHARMA | 150.33 | 120.26 | $371.29B | 2.65% | - | 34.70% | 5.64% | 10.01% |
| 6 | UNH UnitedHealth Group Incorporated SPXR3KPHARMA | 397.14 | 25.54 | $356.47B | 2.33% | 9.74% | 14.15% | 10.40% | 5.43% |
| 7 | NVS Novartis AG PHARMA | 159.99 | 24.20 | $304.10B | 3.03% | 21.09% | 30.35% | 9.25% | 26.22% |
| 8 | AZN AstraZeneca PLC NDXPHARMA | 162.70 | 24.36 | $252.33B | 1.98% | 15.97% | 21.96% | 9.82% | 45.96% |
| 9 | AMGN Amgen Inc. NDXSPXR3KPHARMA | 437.23 | 27.14 | $235.98B | 2.49% | 13.95% | 91.47% | 5.51% | 5.55% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | 500.56M | 501.59M | 505.50M | 494.95M | 476.11M | 462.10M | 455.61M | 446.96M | 449.15M | 452.03M | 435.95M | 407.75M | 398.17M | 415.59M | 426.81M | 424.86M | 414.49M | 417.23M | 418.93M | 411.39M | 423.43M | 426.29M | 428.15M | 447.66M | 458.49M | 464.34M | 462.77M | 470.81M |
| Net Income | 15.52M | 16.29M | 17.09M | 9.13M | 18.63M | 18.76M | 19.71M | 20.30M | 22.02M | 22.55M | 23.47M | 20.19M | 72.00K | 25.81M | 26.09M | 31.55M | 9.16M | 18.19M | 18.34M | 18.89M | 20.19M | 23.10M | 27.64M | 24.65M | 9.56M | 9.54M | 11.33M | 6.82M | 322.00K | 11.67M | 8.25M | -5.05M | 15.31M | -1.79M | 14.03M | 17.23M | -32.37M | 42.95M | 26.06M | 22.70M |
| Diluted EPS | 0.22 | 0.23 | 0.24 | 0.13 | 0.26 | 0.26 | 0.27 | 0.28 | 0.30 | 0.30 | 0.31 | 0.27 | 0.00 | 0.35 | 0.35 | 0.42 | 0.12 | 0.24 | 0.25 | 0.25 | 0.27 | 0.31 | 0.37 | 0.33 | 0.13 | 0.13 | 0.15 | 0.09 | 0.00 | 0.16 | 0.11 | -0.07 | 0.21 | -0.02 | 0.19 | 0.23 | -0.44 | 0.59 | 0.37 | 0.32 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | 1.56B | 1.86B | 2.00B | 1.84B | 1.76B | - | 1.69B | 1.67B | 1.72B | 1.84B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.50B | 1.46B | 1.49B | 1.60B |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 193.31M | 214.75M | 228.09M | 239.41M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 149.52M | 166.77M | 174.82M | 183.60M |
| Operating Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 43.79M | 47.97M | 53.27M | 55.80M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 62.86M | 75.26M | 73.96M | 86.22M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.99M | 7.86M | 6.44M | 1.58M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 44.55M | 53.06M | 52.94M | 67.87M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 10.31M | 14.67M | 13.47M | 8.81M |
| Net Income | 26.61M | 30.34M | 34.44M | 38.16M | 44.21M | 47.13M | 21.85M | 58.02M | 77.40M | 88.23M | 83.52M | 64.58M | 98.68M | - | 34.24M | 38.39M | 39.47M | 59.06M |
| Diluted EPS | 0.40 | 0.46 | 0.51 | 0.56 | 0.65 | 0.67 | 0.31 | 0.80 | 1.05 | 1.19 | 1.12 | 0.87 | 1.32 | - | 0.47 | 0.52 | 0.53 | 0.81 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 265.89M | 277.93M | 289.69M | 331.18M | 425.34M | 469.58M | 480.95M | 528.45M | 676.00M | 692.60M | 722.59M | 785.03M | 779.89M | 720.84M | 790.65M | 802.77M | 794.25M |
| Total Equity | 194.72M | 201.68M | 208.77M | 213.08M | 217.73M | 229.57M | 285.14M | 275.83M | 296.46M | 338.84M | 399.95M | 440.78M | 460.31M | 470.28M | 445.17M | 418.28M | 456.62M | 499.93M | 510.21M |
| Cash & Equivalents | 92.46M | 37.50M | 31.30M | 39.69M | 38.64M | 68.95M | 64.16M | 75.28M | 33.19M | 23.85M | 9.56M | 26.02M | 27.33M | - | - | 26.28M | 54.33M | 56.78M | 125.19M |
| Current Liabilities | - | - | 34.72M | 40.53M | 45.39M | 67.66M | 99.10M | 117.96M | 96.06M | 100.87M | 184.17M | 163.39M | 148.65M | 162.26M | 191.12M | 189.01M | 216.93M | 192.55M | 170.38M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 16.66M | 38.31M | 37.75M | 32.95M | 60.38M | 32.16M | 57.73M | 63.36M | 41.40M | 7.63M | 80.03M | 93.58M | 217.21M | 37.11M | -8.17M | 43.50M | 30.80M | 144.97M |
| Investing Cash Flow | -49.86M | -10.23M | 3.08M | 4.51M | 5.69M | 605.00K | -6.46M | -62.31M | -6.45M | -14.97M | -9.59M | -16.46M | -36.84M | -22.99M | 2.58M | -3.29M | 6.05M | -11.00M |
| Financing Cash Flow | -21.76M | -34.27M | -32.44M | -38.52M | -35.75M | -37.56M | -40.15M | -43.14M | -44.28M | -6.96M | -53.98M | -75.82M | -68.37M | -82.65M | -38.93M | -12.15M | -31.05M | -63.33M |
| Capital Expenditure | -1.58M | -2.15M | -4.17M | -5.54M | -3.48M | -3.76M | -5.79M | -5.00M | -5.44M | -5.40M | -4.94M | -4.37M | -4.34M | -5.69M | -5.21M | -5.41M | -6.34M | -5.82M |
| Free Cash Flow | 15.09M | 36.15M | 33.57M | 27.40M | 56.89M | 28.40M | 51.94M | 58.36M | 35.96M | 2.23M | 75.09M | 89.21M | 212.87M | 31.42M | -13.38M | 38.09M | 24.47M | 139.15M |
| Share Buybacks | 4.65M | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 21.54M | 0 | 11.28M | 5.02M | 61.59M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 11.4% | 12.8% | 13.3% | 13.0% |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.6% | 2.9% | 3.1% | 3.0% |
| Net Margin % | - | - | - | - | - | - | - | - | 5.0% | 4.7% | 4.2% | 3.5% | 5.6% | - | 2.0% | 2.3% | 2.3% | 3.2% |
| ROE % | 13.2% | 14.5% | 16.2% | 17.5% | 19.3% | 16.5% | 7.9% | 19.6% | 22.8% | 22.1% | 18.9% | 14.0% | 21.0% | - | 8.2% | 8.4% | 7.9% | 11.6% |
| ROCE % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8.2% | 8.4% | 8.7% | 8.9% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 16.57% | 11.38M | $255.26M |
| 2 | Vanguard Portfolio Management LLC | 7.40% | 5.08M | $114.00M |
| 3 | Vanguard Capital Management LLC | 4.43% | 3.04M | $68.23M |
| 4 | State Street Corporation | 4.25% | 2.92M | $65.44M |
| 5 | American Century Companies Inc | 3.88% | 2.66M | $59.72M |
| 6 | Geode Capital Management, LLC | 3.73% | 2.56M | $57.49M |
| 7 | Dimensional Fund Advisors LP | 3.62% | 2.48M | $55.76M |
| 8 | FMR, LLC | 3.35% | 2.30M | $51.54M |
| 9 | Ameriprise Financial, Inc. | 3.29% | 2.26M | $50.61M |
| 10 | Royce & Associates LP | 3.26% | 2.24M | $50.25M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for HCSG
Is Healthcare Services Group (HCSG) Stock Outpacing Its Business Services Peers This Year? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxOREEwVEVuQWZXemVJMTYzTmt1Ujg5SzVaNDNhLUp2eE4xTU4zbU9HdFVSY3RMdW5wQ096enNiUTVsc0Q0UDY5cnp2dGloZU5XM20waUZfbldOeXVIVkNUazNMZ3AzS1pQSGU1bVlDdGxvc2JOdXItb2gwWDhNUXF4cjh2bC02YTAtWV94cD…
Healthcare Services Group (HCSG) Gains On Earnings View As Undervalued Narrative Holds - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi8AFBVV95cUxPLU1VbWZmREhybmJhb24td2R6TUwyTXJrUXBnM1VWOVhrLVZpcTZXbFVfSFlDT2JyckZwNmpncDVnVm5IMV9lTVNLRUktbFZUT0VhNXBxYnBFVVgzODdwUWQ3S3plWEJSQVRnTnFtVnRRWUJ3bndhVExUZ0o1eEtmVnlPSWo1RkxFa3YwNG…
Healthcare Services Group: Operational Improvements Support Further Upside (NASDAQ:HCSG) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxPMVlJdC1ZOHJVZnloQ080MTBlYWpIcnlsMzZhSmxxOWtLS1dJVWhXWklmdUhiaF9ieHhSdVJoVmQyNlJ5LXM5djRQOUhDMTRQal8ycHEzTkZIRjdCVEFsNkpWUnVBb1pudEJuREhZZGpxTG5UbXRlZ3J2SGtLeDY5Z0FCbVZPWjBQeWRlR0…
Legal & General Group Plc Acquires Shares of 169,760 Healthcare Services Group, Inc. $HCSG - marketbeat.com
<a href="https://news.google.com/rss/articles/CBMi3gFBVV95cUxNaXhFaThOcmZzVjZPS2EtTlNpSU9Ubk1kNk55M3RUZExHX2otak03YUhkTFZlYkZuZVVjeWNjQm13Uml0ZnlGVW1SelJidHJDWlpMaXVhbWFWZU5zOERxcTk2VHRNeU05S1N0eG9DOXYtZk5jei1OUWhkYWxzWnlGT2tBbE1vZEctVDhZU2…
It's Not The Next Nvidia, But This Stock's Steady Climb Rewards Patient Investors - Investor's Business Daily
<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxQeFBkZm8wbWZGX1BjdHVRSi01b2RTcE41Qi1wcUpFakxRRkJ3MzZBNmp2UzdEYzBwRFdIWHVWZ3FReUFNY19yM2M0WjhKcFgxMWlNNjFqUmZPNDlSV1NveGx3d0tKZzVJcUh2T01qa2xjcFk5ZnAtekV2WDMzZnpObHJPZURsWUt0ZDdrRU…
Is Healthcare Services Group (HCSG) Outperforming Other Business Services Stocks This Year? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxOeGF4aUZ6eUpINEVFU3NaLVhjS3Bock1HYndySzlNQ3JSUXVzWXZwSlJlMVh1WkRMWkJsMWJKcVVRZGM5M2R5dGNqcHpNaVA5S3VNN0JROHZfRzc0UzMxRkdsMllBZEU5UXhXVG1QTnhNUld3X2dPUHZqR1lUSWlfcjZBcnRTRThZRnZjM0…
HCSG — Frequently Asked Questions
What is the current share price of Healthcare Services Group, Inc. (HCSG)?
As of 2026-09-07 16:24 PDT, Healthcare Services Group, Inc. (HCSG) trades at $21.82 on NasdaqGS. Its 52-week range is $15.02 to $25.31.
What is the market capitalisation of HCSG?
Healthcare Services Group, Inc. (HCSG) has a market capitalisation of $1.50B on NasdaqGS.
What is the P/E ratio of HCSG?
HCSG trades at a trailing price-to-earnings (P/E) ratio of 12.76. The industry average P/E is 25.17. Its price-to-book (P/B) ratio is 2.91.
What is the return on equity (ROE) of HCSG?
HCSG has a return on equity (ROE) of 24.69%. Its return on capital employed (ROCE) is 8.94%.
Is HCSG a good stock to buy?
This page provides a data-driven analysis of Healthcare Services Group, Inc. (HCSG), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.